CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
HA IDF (YVOIRE classic) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03738020
NCT03738020N/ACompleted

A Randomized, Multi Center, Single-blind, Active-controlled, Matched Pairs Design Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of HA IDF Versus Restylane in Nasolabial Fold Intradermal Injection

LG Life Sciences·interventional·Posted Nov 13, 2018·Updated Dec 18, 2019

In Brief

A clinical study evaluating HA IDF (YVOIRE classic) and Restylane for Temporary Correction of Wrinkles. Completed, enrolled 58 participants.

Detailed Summary

This study was purposed to evaluate the non-inferiority of HA IDF, a hyaluronic acid product, in terms of correction of wrinkles and safety in nasolabial fold intradermal injection, compared to Restylane, the control preparation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 13, 2018
Enrollment StartJan 1, 2009
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.6 years ago

Interventions

HA IDF (YVOIRE classic)device

Treatment with HA IDF

Restylanedevice

Treatment with Restylane